A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Clinical trial NCT06832618 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06832618
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-17
- Primary completion
- 2026-08-07
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.